Skip to main content
. 2023 Aug 4;229(2):432–442. doi: 10.1093/infdis/jiad308

Table 3.

Factors Associated With Kaposi Sarcoma–Associated Herpesvirus (KSHV) Antibody Levels Among KSHV-Seropositive Children

Factor Crude Adjusteda
Regression Coefficient (95% CI) P Value Regression Coefficient (95% CI) P Value
Malaria
 RDT/PfPCR (uninfected) Ref .007* (trend) Ref .014* (trend)
 RDT/PfPCR+ 0.12 (−.09 to .33) 0.13 (−.09 to .35)
 RDT+/PfPCR+ 0.24 (.06–.43) 0.25 (.06–.45)
Age, y 0.03 (−.01 to .07) .201 0.03 (−.01 to .07) .190
Sex
 Male Ref .935 Ref .867
 Female −0.006 (−.15 to .13) −0.01 (−.15 to .13)
Anemia
 Normal (Hb ≥11.5 g/dL) Ref .975 Ref .616
 Anemic (Hb <11.5 g/dL) 0.002 (−.15 to .16) −0.04 (−.20 to .12)
Body temperature (axillary)
 ≤37.5°C Ref .994 Ref .554
 >37.5°C 0.001 (−.16 to .17) −0.05 (−.22 to .12)

Immunoglobulin G (IgG) to 25 Kaposi sarcoma–associated herpesvirus (KSHV) recombinant proteins was measured using multiplex bead assay. IgG median fluorescent intensity to the 25 KSHV proteins were summed and log10 transformed before linear regression modeling.

Abbreviations: CI, confidence interval; Hb, hemoglobin; PCR, Plasmodium falciparum polymerase chain reaction negative; PCR+, Plasmodium falciparum polymerase chain reaction positive; RDT, rapid diagnostic test negative; RDT+, rapid diagnostic test positive.

aAdjusted for age, sex, anemia, body temperature, and malaria parasitemia. RDTs and quantitative real-time PCR were used to determine malaria parasitemia.

* P < .05 considered statistically significant.